What are telomeres?

Telomeres are repetitive DNA sequences that protect the ends of each chromosome. Telomeres shorten with every cell division due to the ‘end replication problem’ and with DNA damage. Telomeres shorten with age and in disease (Blackburn, 2015). Long telomeres form a loop that prevents the DNA end from acting as broken DNA.  Short telomeres cause the loop to fail to form, exposing the DNA end, triggering DNA damage response pathways, resulting in cell senescence and cell death.  Short telomeres also cause chromosome-chromosome fusions which can cause chromosomal rearrangements which can lead to cancer (Blackburn, 2011).

Telomeres (yellow) at the ends of chromosomes (blue).

Healthy-length telomeres are essential for your health

  • Telomeres are DNA sequences at the end of each chromosome
  • Telomeres protect every DNA tip by forming a loop
  • Short telomeres result in non-functional cells
  • Short telomere can’t form loop
  • Activates DNA damage response
  • Chromosomes fuse
  • Cell dies or senesces
  • Organism ages

Telomeres are a biological clock

Problem:  Telomeres shorten as we age, causing death and disease

Solution:  TERT mRNA extends telomeres

People with healthy-length telomeres have longer healthspans

On average people with longer telomeres live longer than people with shorter telomeres, even controlling for smoking, blood pressure, cholesterol level, BMI, age, and gender (Rode, 2015).  Short telomeres correlate with early death, hypertension, cardiovascular disease, cancer, chronic infection, diabetes (reviewed in Weischer, 2014), Alzheimer’s disease (Thomas, 2008), and risk of post-stroke dementia (Martin-Ruiz, 2006). In human twin pairs, the twin with the shorter telomeres is more likely to die first (Kimura, 2008). 

Telomere extension in old normal mice improves multiple aspects of aging, including neurological function, strength, insulin levels, and IGF-1 levels, and extends lifespan by 24% (Jaskelioff, 2011; Bernardes de Jesus, 2012).  Telomere extension rescues animal models of disease including liver disease and pulmonary fibrosis (Rudolph, 2000; Povedano, 2018). 

Because of the abundant evidence that short telomeres are unhealthy or fatal, and that telomere extension improves health and reverses symptoms of aging, therapeutic telomere extension has been advocated since the last century.  

It has been known for over 35 years that the enzyme telomerase reverse transcriptase (TERT) extends telomeres.  But it was only in 2013 and 2019 that inventions at Stanford University enabled safe, rapid telomere extension by delivery of nucleoside-modified TERT mRNA (Ramunas, 2015).

Nucleoside-modified TERT mRNA rapidly extends telomeres

Nucleoside-modified TERT mRNA can be used to extend telomeres in vitro or in vivo. TERT mRNA is translated into TERT protein, which goes to the nucleus and extends telomeres rapidly. The TERT protein is degraded within days, but during that brief time telomeres are extended rapidly, reversing a deacde of telomere shortening in days. The extended telomeres resume shortening immediately after treatment, important for safety.

Nucleoside-modified TERT mRNA increases telomerase activity in cells briefly (left). During this brief time telomeres are extended rapidly, by about 1 kb in a few days. This is the equivalent of reversing decades of telomere shortening during normal aging (middle). The treated cells are able to divide more times, but are not immortalized. The amount of telomere extension depends on the dose of TERT mRNA (right). TERT mRNA treatment delays senescence, rejuvenates old cells, and keeps young cells young longer (Ramunas, 2015).

We are moving TERT mRNA rapidly toward clinical trials. We also offer TeloAid, which is TERT mRNA for research use.